TrialMatch

Sign in Sign up Create account

Search the registry

Find clinical trials

Searching 2,585 mirrored studies from ClinicalTrials.gov. Create a profile to see personalised match scores.

Filters

Clear all

2,585 studies found

Sort by

Recruiting

Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

1 site

Compare

Recruiting

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Phase 2 · 111 sites

Compare

Recruiting

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

1 site

Compare

Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Phase 2 · 108 sites

Compare

Recruiting

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Phase 2 · 189 sites

Compare

Recruiting

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

2 sites

Compare

Recruiting

Evaluation for NCI Surgery Branch Clinical Research Protocols

1 site

Compare

Recruiting

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Phase 2 · 1 site

Compare

Recruiting

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Phase 1 · 2 sites

Compare

Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Phase 3 · 224 sites

Compare

Recruiting

Assessment of Geriatric Evaluations Impact on New AML Guidance

1 site

Compare

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Phase 2 / Phase 3 · 36 sites

Compare

Potential match only. Final eligibility is determined by the study team.